Antiviral approaches for cancers related to Epstein-Barr virus and human papillomavirus
- 1 October 2001
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 2 (10), 622-630
- https://doi.org/10.1016/s1470-2045(01)00520-4
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Epstein–Barr Virus InfectionNew England Journal of Medicine, 2000
- Expression of the Epstein–Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic miceProceedings of the National Academy of Sciences, 1998
- Latent membrane protein 1of Epstein-Barr virus mimics a constitutively active receptor moleculeThe EMBO Journal, 1997
- Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.Proceedings of the National Academy of Sciences, 1993
- Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus.Journal of Clinical Pathology, 1993
- EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene productsBritish Journal of Haematology, 1992
- Viruses in Human CancersScience, 1991
- Detection of Epstein–Barr Viral Genomes in Reed–Sternberg Cells of Hodgkin's DiseaseNew England Journal of Medicine, 1989
- The differentiated form of nasopharyngeal carcinoma contains epstein‐barr virus DNAInternational Journal of Cancer, 1987
- A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.Proceedings of the National Academy of Sciences, 1984